Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000878361 | SCV001021257 | likely benign | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501354 | SCV002808417 | likely benign | Pigmented paravenous retinochoroidal atrophy; Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454925 | SCV004180099 | likely benign | Leber congenital amaurosis 8 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454926 | SCV004180100 | likely benign | Pigmented paravenous retinochoroidal atrophy | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454924 | SCV004180101 | likely benign | Retinitis pigmentosa 12 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004711359 | SCV005261007 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001271903 | SCV001453397 | uncertain significance | Leber congenital amaurosis | 2020-01-07 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004530881 | SCV004731060 | likely benign | CRB1-related disorder | 2023-04-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |